Through a potential $1.37 billion deal, New York-headquartered Yarrow gains ex-China rights to a potential first-in-class ...

("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today announced an exclusive global ex-China license agreement for GS-098, a clinical-stage, first-in-class, humanized ...

Doctronic reports that AI healthcare visits primarily involve managing chronic conditions like thyroid disorders, diabetes, ...

Poorly controlled thyroid disease with persistent imbalance across trimesters is associated with an increased risk for autism ...

Vyvgart, an FcRn inhibitor already approved for generalized myasthenia gravis, is also being tested in myositis, Sjögren’s ...

Thyroid disorders, common endocrine conditions, often require long-term management. Shivkumar Aggarwal, seeking lasting ...

Medically reviewed by Kelly Wood, MDKey TakeawaysThyroid blood tests help figure out how well your thyroid gland is ...

In a real-world study of the use of immune checkpoint inhibitors (ICIs), approximately half of patients with advanced cancers developed thyroid dysfunction related to the cancer treatment within about ...

Argenx SE shares fell the most in seven months after the biotech firm said it will discontinue late-stage trials for an experimental medicine to treat an autoimmune disease affecting the eyes.

Thyroid disorders affect approximately 12% of people worldwide, but women experience these conditions at rates up to eight times higher than men. This stark gender disparity stems from complex ...

Researchers have found that ongoing thyroid hormone imbalance in pregnancy may be linked to higher autism risk in children. Treated thyroid disorders did not show the same effect. The longer the ...